Todays EPS

Trading Code: GENNEXT
News Title: GENNEXT: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 0.15 for October-December, 2019 as against Tk. 0.20 for October-December, 2018; EPS was Tk. 0.35 for July-December, 2019 as against Tk. 0.45 for July-December, 2018. NOCFPS was Tk. 0.06 for July-December, 2019 as against Tk. 0.20 for July-December, 2018. NAV per share was Tk. 12.24 as on December 31, 2019 and Tk. 11.89 as on June 30, 2019.

 

Trading Code: OLYMPIC
News Title: OLYMPIC: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 2.47 for October-December 2019 as against Tk. 2.20 for October-December 2018; EPS was Tk. 5.26 for July-December 2019 as against Tk. 4.60 for July-December 2018. NOCFPS was Tk. 5.36 for July-December 2019 as against Tk. 4.52 for July-December 2018. NAV per share was Tk. 36.35 as on December 31, 2019 and Tk. 31.33 as on December 31, 2018.

 

Trading Code: ACIFORMULA
News Title: ACIFORMULA: Q2 Financials
News: (Continuation news of ACIFORMULA): It is to be noted that EPS was decreased due to falling rice price, lower revenue in some portfolio and increase seasonal bonus, trade incentives, reimbursement of distribution cost. NOCFPS was increased due to better working capital management. (end)

 

Trading Code: FEKDIL
News Title: FEKDIL: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 0.21 for October-December, 2019 as against Tk. 0.34 for October-December, 2018; EPS was Tk. 0.12 for July-December, 2019 as against Tk. 0.60 for July-December, 2018. NOCFPS was Tk. (0.67) for July-December, 2019 as against Tk. 0.88 for July-December, 2018. NAV per share was Tk. 19.15 as on December 31, 2019 and Tk. 20.48 as on June 30, 2019.

 

Trading Code: ACIFORMULA
News Title: ACIFORMULA: Q2 Financials
News: (Q2 Un-audited): Consolidated EPS was Tk. 1.02 for October-December 2019 as against Tk. 1.81 for October-December 2018; Consolidated EPS was Tk. 1.17 for July-December 2019 as against Tk. 2.20 for July-December 2018. Consolidated NOCFPS was Tk. 4.77 for July-December 2019 as against Tk. (10.87) for July-December 2018. Consolidated NAV per share was Tk. 52.49 as on December 31, 2019 and Tk. 54.82 as on June 30, 2019. (Cont.)

 

Trading Code: EBLNRBMF
News Title: EBLNRBMF: Q2 Financials
News: (Q2 Un-audited): EPU was Tk. (0.30) for October-December 2019 as against Tk. 0.12 for October-December 2018; EPU was Tk. (0.45) for July-December 2019 as against Tk. 0.16 for July-December 2018. NOCFPU was Tk. 0.15 for July- December 2019 as against Tk. 0.22 for July- December 2018. NAV per unit at market price was Tk. 10.08 as on December 31, 2019 and Tk. 10.83 as on June 30, 2019. NAV per unit at cost price was Tk. 10.78 as on December 31, 2019 and Tk. 10.96 as on June 30, 2019.

 

Trading Code: FINEFOODS
News Title: FINEFOODS: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 0.501 for October-December, 2019 as against Tk. 0.007 for October-December, 2018; EPS was Tk. 0.845 for July-December, 2019 as against Tk. 0.033 for July-December, 2018. NOCFPS was Tk. (0.140) for July-December, 2019 as against Tk. (0.123) for July-December, 2018. NAV per share was Tk. 11.482 as on December 31, 2019 and Tk. 10.623 as on December 31, 2018.

 

Trading Code: ZAHEENSPIN
News Title: ZAHEENSPIN: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. (0.92) for October-December 2019 as against Tk. 0.18 for October-December 2018; EPS was Tk. (0.83) for July-December 2019 as against Tk. 0.45 for July-December 2018. NOCFPS was Tk. 0.20 for July-December 2019 as against Tk. 0.26 for July-December 2018. NAV per share was Tk. 11.98 as on December 31, 2019 and Tk. 12.81 as on June 30, 2019.

 

Trading Code: DELTASPINN
News Title: DELTASPINN: Q2 Financials
News: (Continuation news of DELTASPINN): It is to be noted that the Company has not yet declared their Board Meeting date as per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, to consider, among others, audited financial statements of the Company for the year ended on June 30, 2019. (end)

 

Trading Code: DELTASPINN
News Title: DELTASPINN: Q2 Financials
News: (Q2 Un-audited): Consolidated EPS was Tk. 0.06 for October-December 2019 as against Tk. 0.06 for October-December 2018; Consolidated EPS was Tk. 0.12 for July-December 2019 as against Tk. 0.13 for July-December 2018. Consolidated NOCFPS was Tk. 0.06 for July-December 2019 as against Tk. 0.08 for July-December 2018. Consolidated NAV per share was Tk. 13.72 as on December 31, 2019 and Tk. 13.59 as on June 30, 2019. (cont.)

 

Trading Code: AMBEEPHA
News Title: AMBEEPHA: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 0.88 for October-December, 2019 as against Tk. 0.85 for October-December, 2018; EPS was Tk. 1.63 for July-December, 2019 as against Tk. 1.69 for July-December, 2018. NOCFPS was Tk. 0.07 for July-December, 2019 as against Tk. 5.66 for July-December, 2018. NAV per share was Tk. 22.72 as on December 31, 2019 and Tk. 24.09 as on June 30, 2019.

 

Trading Code: KBPPWBIL
News Title: KBPPWBIL: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. (0.01) for October-December 2019 as against Tk. 0.06 for October-December 2018; EPS was Tk. (0.06) for July-December 2019 as against Tk. 0.16 for July-December 2018. NOCFPS was Tk. 0.13 for July-December 2019 as against Tk. 0.59 for July-December 2018. NAV per share was Tk. 12.58 as on December 31, 2019 and Tk. 12.64 as on June 30, 2019.

 

Trading Code: OAL
News Title: OAL: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. (0.13) for October-December 2019 as against Tk. 0.14 for October-December 2018; EPS was Tk. (0.33) for July-December 2019 as against Tk. 0.29 for July-December 2018. NOCFPS was Tk. 0.40 for July-December 2019 as against Tk. 0.71 for July-December 2018. NAV per share was Tk. 14.16 as on December 31, 2019 and Tk. 14.65 as on June 30, 2019.

 

Trading Code: ACMELAB
News Title: ACMELAB: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 1.77 for October-December, 2019 as against Tk. 1.85 for October-December, 2018; EPS was Tk. 3.66 for July-December, 2019 as against Tk. 3.69 for July-December, 2018. NOCFPS was Tk. 1.98 for July-December, 2019 as against Tk. 4.61 for July-December, 2018. NAV per share was Tk. 86.82 as on December 31, 2019 and Tk. 86.69 as on June 30, 2019.

 

Trading Code: SQURPHARMA
News Title: SQURPHARMA: Q2 Financials
News: (Q2 Un-audited): Consolidated EPS was Tk. 4.18 for October-December 2019 as against Tk. 3.70 for October-December 2018; Consolidated EPS was Tk. 8.16 for July-December 2019 as against Tk. 7.46 for July-December 2018. Consolidated NOCFPS was Tk. 5.88 for July-December 2019 as against Tk. 6.83 for July-December 2018. Consolidated NAV per share was Tk. 84.12 as on December 31, 2019 and Tk. 80.40 as on June 30, 2019.

 

Trading Code: ABB1STMF
News Title: ABB1STMF: Q2 Financials
News: (Q2 Un-audited): EPU was Tk. (0.73) for October-December, 2019 as against Tk. 0.14 for October-December, 2018; EPU was Tk. (0.92) for July-December, 2019 as against Tk. 0.20 for July-December, 2018. NOCFPU was Tk. 0.31 for July- December, 2019 as against Tk. 0.22 for July- December, 2018. NAV per unit at market price was Tk. 9.98 as on December 31, 2019 and Tk. 11.19 as on June 30, 2019. NAV per unit at cost price was Tk. 11.40 as on December 31, 2019 and Tk. 11.41 as on June 30, 2019.

 

Trading Code: PHPMF1
News Title: PHPMF1: Q2 Financials
News: (Q2 Un-audited): EPU was Tk. (0.27) for October-December 2019 as against Tk. 0.16 for October-December 2018; EPU was Tk. (0.38) for July-December 2019 as against Tk. 0.17 for July-December 2018. NOCFPU was Tk. 0.17 for July- December 2019 as against Tk. 0.13 for July- December 2018. NAV per unit at market price was Tk. 10.07 as on December 31, 2019 and Tk. 10.75 as on June 30, 2019. NAV per unit at cost price was Tk. 10.82 as on December 31, 2019 and Tk. 10.99 as on June 30, 2019.
Trading Code: POPULAR1MF
News Title: POPULAR1MF: Q2 Financials
News: (Q2 Un-audited): EPU was Tk. (0.29) for October-December 2019 as against Tk. 0.13 for October-December 2018; EPU was Tk. (0.47) for July-December 2019 as against Tk. 0.27 for July-December 2018. NOCFPU was Tk. 0.27 for July- December 2019 as against Tk. (0.05) for July- December 2018. NAV per unit at market price was Tk. 10.13 as on December 31, 2019 and Tk. 10.90 as on June 30, 2019. NAV per unit at cost price was Tk. 11.08 as on December 31, 2019 and Tk. 11.16 as on June 30, 2019.
Trading Code: VAMLBDMF1
News Title: VAMLBDMF1: Q1 Financials
News: (Q1 Un-audited): EPU was Tk. (0.90) for October-December 2019 as against Tk. 0.24 for October-December 2018. NOCFPU was Tk. 0.03 for October-December 2019 as against Tk. 0.01 for October-December 2018. NAV per unit at market price was Tk. 9.31 as on December 31, 2019 and Tk. 10.22 as on September 30, 2019. NAV per unit at cost price was Tk. 11.21 as on December 31, 2019 and Tk. 11.03 as on September 30, 2019.

 

Trading Code: ATCSLGF
News Title: ATCSLGF: Q2 Financials
News: (Q2 Un-audited): EPU was Tk. (0.55) for October-December 2019 as against Tk. 0.21 for October-December 2018; EPU was Tk. (0.64) for July-December 2019 as against Tk. 0.59 for July-December 2018. NOCFPU was Tk. (0.00) for July- December 2019 as against Tk. 0.55 for July- December 2018. NAV per unit at market price was Tk. 11.11 as on December 31, 2019 and Tk. 12.95 as on June 30, 2019. NAV per unit at cost price was Tk. 11.76 as on December 31, 2019 and Tk. 12.49 as on June 30, 2019.

 

Trading Code: NTC
News Title: NTC: Q2 Financials (Additional Information)
News: (Q2 Un-audited Additional Information): The Company has further informed that EPS was decreased due to decrease in auction price compared to last year of the same period.
Trading Code: SPCERAMICS
News Title: SPCERAMICS: Q2 Financials (Correction)
News: (Correction): (Q2 Un-audited): NAV per share was Tk. 28.84 as on December 31, 2018 instead of Tk. 29.04.

 

Trading Code: USMANIAGL
News Title: USMANIAGL: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. (1.04) for October-December 2019 as against Tk. (0.52) for October-December 2018; EPS was Tk. (2.40) for July-December 2019 as against Tk. (1.48) for July-December 2018. NOCFPS was Tk. (3.13) for July-December 2019 as against Tk. 0.04 for July-December 2018. NAV per share was Tk. 97.24 as on December 31, 2019 and Tk. 99.65 as on June 30, 2019.

 

Trading Code: ZEALBANGLA
News Title: ZEALBANGLA: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. (15.80) for October-December 2019 as against Tk. (18.70) for October-December, 2018; EPS was Tk. (35.50) for July-December 2019 as against Tk. (36.27) for July-December 2018. NOCFPS was Tk. (34.69) for July-December 2019 as against Tk. (35.14) for July-December 2018. NAV per share was Tk. (643.27) as on December 31, 2019 and Tk. (607.76) as on June 30, 2019.

 

Trading Code: SPCERAMICS
News Title: SPCERAMICS: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 0.04 for October-December 2019 as against Tk. 0.11 for October-December 2018; EPS was Tk. 0.06 for July-December 2019 as against Tk. 0.21 for July-December 2018. NOCFPS was Tk. 0.87 for July-December 2019 as against Tk. 0.42 for July-December 2018. NAV per share was Tk. 28.94 as on December 31, 2019 and Tk. 29.04 as on December 31, 2018.

 

Trading Code: RENWICKJA
News Title: RENWICKJA: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 0.99 for October-December 2019 as against Tk. 2.32 for October-December 2018; EPS was Tk. 1.71 for July-December 2019 as against Tk. 3.02 for July-December 2018. NOCFPS was Tk. (2.03) for July-December 2019 as against Tk. 3.817 for July-December 2018. NAV per share was Tk. 32.37 as on December 31, 2019 and Tk. 30.66 as on June 30, 2019.

 

Trading Code: SHYAMPSUG
News Title: SHYAMPSUG: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. (22.74) for October-December 2019 as against Tk. (27.93) for October-December 2018; EPS was Tk. (46.04) for July-December 2019 as against Tk. (44.61) for July-December 2018. NOCFPS was Tk. 4.48 for July-December 2019 as against Tk. (43.85) for July-December 2018. NAV per share was Tk. (914.01) as on December 31, 2019 and Tk. (867.97) as on June 30, 2019.

 

Trading Code: BXSYNTH
News Title: BXSYNTH: Q2 Financials
News: Q2 Un-audited): EPS was Tk. (0.72) for October-December 2019 as against Tk. (0.84) for October-December 2018; EPS was Tk. (1.40) for July-December 2019 as against Tk. (1.71) for July-December 2018. NOCFPS was Tk. 1.78 for July-December 2019 as against Tk. 0.09 for July-December 2018. NAV per share was Tk. 12.73 as on December 31, 2019 and Tk. 14.13 as on June 30, 2019.

 

Trading Code: MICEMENT
News Title: MICEMENT: Q2 Financials
News: Continuation news of MICEMENT): NOCFPS was significantly decreased Tk. 182.00 crore due to following reasons : i) Higher buildup of inventory to offset adverse movement in prices, advances to suppliers and higher prices of raw materials. (ii) Higher accounts receivables due to intense competition in the market leading to higher credit given by all cement manufacturers to the channel. (iii) Decrease in financial income due to sharp drop in fixed deposits in this period. (end)

 

Trading Code: MICEMENT
News Title: MICEMENT: Q2 Financials
News: (Continuation news of MICEMENT): EPS was decreased significantly due to finance cost has been increased by Tk. 2.18 Crore. Interest income has dropped by Tk. 6.37 Crore. Current tax is also increased by Tk. 22.58 Crore in this period in comparison with previous year. As a result, net profit after tax is decreased by Tk. 39.57 crore which results in EPS decreased to Tk. (1.89) in the half year ended 2019-20 in comparison with corresponding period of last year. (Cont. 2)

 

Trading Code: MICEMENT
News Title: MICEMENT: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. (1.80) for October-December 2019 as against Tk. 0.31 for October-December 2018; EPS was Tk. (1.89) for July-December 2019 as against Tk. 0.78 for July-December 2018. NOCFPS was Tk. (9.99) for July-December 2019 as against Tk. 2.34 for July-December 2018. NAV per share was Tk. 45.36 as on December 31, 2019 and Tk. 48.22 as on June 30, 2019. (Cont. 1)

 

Trading Code: NTC
News Title: NTC: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. (1.27) for October-December 2019 as against Tk. 7.75 for October-December 2018; EPS was Tk. 6.62 for July-December 2019 as against Tk. 27.55 for July-December 2018. NOCFPS was Tk. 1.63 for July-December 2019 as against Tk. 51.17 for July-December 2018. NAV per share was Tk. 179.08 as on December 31, 2019 and Tk. 174.66 as on June 30, 2019.

 

Trading Code: BEXIMCO
News Title: BEXIMCO: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 0.23 for October-December 2019 as against Tk. 0.40 for October-December 2018; EPS was Tk. 0.54 for July-December 2019 as against Tk. 0.79 for July-December 2018. NOCFPS was Tk. 0.75 for July-December 2019 as against Tk. 0.16 for July-December 2018. NAV per share was Tk. 69.39 as on December 31, 2019 and Tk. 69.83 as on June 30, 2019.

 

Trading Code: POWERGRID
News Title: POWERGRID: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 1.50 for October-December 2019 as against Tk. 0.99 for October-December 2018; EPS was Tk. 3.35 for July-December 2019 as against Tk. 2.57 for July-December 2018. NOCFPS was Tk. 5.24 for July-December 2019 as against Tk. 6.21 for July-December 2018. NAV per share was Tk. 106.57 as on December 31, 2019 and Tk. 80.24 as on December 31, 2018.

 

Trading Code: APEXFOOT
News Title: APEXFOOT: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 4.13 for October-December 2019 as against Tk. 2.11 for October-December 2018; EPS was Tk. 5.18 for July-December 2019 as against Tk. 6.03 for July-December 2018. NOCFPS was Tk. 63.66 for July-December 2019 as against Tk. 58.06 for July-December 2018. NAV per share was Tk. 249.51 as on December 31, 2019 and Tk. 249.83 as on June 30, 2019.

 

Trading Code: BBS
News Title: BBS: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 0.49 for October-December 2019 as against Tk. 0.56 for October-December 2018; EPS was Tk. 0.98 for July-December, 2019 as against Tk. 1.09 for July-December 2018. NOCFPS was Tk. 0.20 for July-December 2019 as against Tk. 0.45 for July-December 2018. NAV per share was Tk. 15.99 as on December 31, 2019 and Tk. 15.00 as on June 30, 2019.

 

Trading Code: ALLTEX
News Title: ALLTEX: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. (1.45) for October-December 2019 as against Tk. (1.14) for October-December 2018; EPS was Tk. (2.89) for July-December 2019 as against Tk. (2.99) for July-December 2018. NOCFPS was Tk. 0.53 for July-December 2019 as against Tk. 0.49 for July-December 2018. NAV per share was Tk. 9.16 as on December 31, 2019 and Tk. 12.05 as on June 30, 2019.
Trading Code: TITASGAS
News Title: TITASGAS: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 0.90 for October-December 2019 as against Tk. 0.89 for October-December 2018; EPS was Tk. 1.62 for July-December 2019 as against Tk. 2.14 for July-December 2018. NOCFPS was Tk. (0.33) for July-December 2019 as against Tk. 10.51 for July-December 2018. NAV per share was Tk. 69.27 as on December 31, 2019 and Tk. 70.08 as of June 30, 2019.

 

Trading Code: RENATA
News Title: RENATA: Q2 Financials
News: (Q2 Un-audited): Consolidated EPS was Tk. 10.83 for October-December 2019 as against Tk. 9.65 for October-December 2018; Consolidated EPS was Tk. 22.45 for July-December 2019 as against Tk. 19.16 for July-December 2018. Consolidated NOCFPS was Tk. 20.33 for July-December 2019 as against Tk. 32.12 for July-December 2018. Consolidated NAV per share was Tk. 222.91 as on December 31, 2019 and Tk. 209.91 as on June 30, 2019.

 

Trading Code: BXPHARMA
News Title: BXPHARMA: Q2 Financials
News: (Q2 Un-audited): Consolidated EPS was Tk. 2.12 for October-December 2019 as against Tk. 1.81 for October-December 2018; Consolidated EPS was Tk. 4.26 for July-December 2019 as against Tk. 3.67 for July-December 2018. Consolidated NOCFPS was Tk. 9.14 for July-December 2019 as against Tk. 2.10 for July-December 2018. Consolidated NAV per share was Tk. 75.66 as on December 31, 2019 and Tk. 69.15 as on December 31, 2018.

 

Trading Code: UNIQUEHRL
News Title: UNIQUEHRL: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 0.55 for October-December 2019 as against Tk. 0.72 for October-December 2018; EPS was Tk. 1.02 for July-December 2019 as against Tk. 1.25 for July-December 2018. NOCFPS was Tk. 2.23 for July-December 2019 as against Tk. 2.95 for July-December 2018. NAV per share was Tk. 79.76 as on December 31, 2019 and Tk. 80.69 as on June 30, 2019.

 

 

Trading Code: ECABLES
News Title: ECABLES: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. (1.51) for October-December 2019 as against Tk. (1.22) for October-December 2018; EPS was Tk. (3.00) for July-December 2019 as against Tk. (2.72) for July-December 2018. NOCFPS was Tk. (9.80) for July-December 2019 as against Tk. (6.89) for July-December 2018. NAV per share was Tk. 19.07 as on December 31, 2019 and Tk. 22.07 as on June 30, 2019.

 

Trading Code: BBSCABLES
News Title: BBSCABLES: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 2.37 for October-December 2019 as against Tk. 2.57 for October-December 2017; EPS was Tk. 4.87 for July-December 2019 as against Tk. 4.99 for July-December 2018. NOCFPS was Tk. 3.49 for July-December 2019 as against Tk. 3.93 for July-December 2018. NAV per share was Tk. 30.73 as on December 31, 2019 and Tk. 26.77 as on June 30, 2019.

 

Trading Code: KDSALTD
News Title: KDSALTD: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 0.91 for October-December 2019 as against Tk. 0.82 for October-December 2018; EPS was Tk. 1.25 for July-December 2019 as against Tk. 1.05 for July-December 2018. NOCFPS was Tk. 5.27 for July-December 2019 as against Tk. (2.44) for July-December 2018. NAV per share was Tk. 24.05 as on December 31, 2019 and Tk. 24.94 as on June 30, 2019.

 

Trading Code: HRTEX
News Title: HRTEX: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 0.46 for October-December 2019 as against Tk. 0.45 for October-December 2018; EPS was Tk. 0.88 for July-December 2019 as against Tk. 0.83 for July-December 2018. NOCFPS was Tk. (3.55) for July-December 2019 as against Tk. (3.75) for July-December 2018. NAV per share was Tk. 43.78 as on December 31, 2019 and Tk. 43.40 as on June 30, 2019.

 

Trading Code: VFSTDL
News Title: VFSTDL: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 0.61 for October-December 2019 as against Tk. 0.59 for October-December 2018; EPS was Tk. 1.04 for July-December 2019 as against Tk. 1.02 for July-December 2018. NOCFPS was Tk. 0.40 for July-December 2019 as against Tk. 0.37 for July-December 2018. NAV per share was Tk. 17.48 as on December 31, 2019 and Tk. 17.67 as on December 31, 2018.

 

Trading Code: NTLTUBES
News Title: NTLTUBES: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 0.09 for October-December 2019 as against Tk. (0.24) for October-December 2018; EPS was Tk. 0.24 for July-December 2019 as against Tk. (0.83) for July-December 2018. NOCFPS was Tk. 1.07 for July-December 2019 as against Tk. (0.11) for July-December 2018. NAV per share was Tk. 159.40 as on December 31, 2019 and Tk. 175.30 as on June 30, 2019.

 

Trading Code: BSCCL
News Title: BSCCL: Q2 Financials
News: (Continuation news of BSCCL): EPS was increased due to increase in revenue and no significant additional expenditure against the increased revenue, expenditure has been reduced in some head of Expenditure. There was no Extraordinary Transactions during this period. (end)

 

Trading Code: BENGALWTL
News Title: BENGALWTL: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 0.18 for October-December 2019 as against Tk. 0.33 for October-December 2018; EPS was Tk. 0.46 for July-December 2019 as against Tk. 0.65 for July-December 2018. NOCFPS was Tk. 0.85 for July-December 2019 as against Tk. 0.83 for July-December 2018. NAV per share was Tk. 24.74 as on December 31, 2019 and Tk. 24.78 as on June 30, 2019.

 

Trading Code: BSCCL
News Title: BSCCL: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. 1.22 for October-December 2019 as against Tk. 0.96 for October-December 2018; EPS was Tk. 2.26 for July-December 2019 as against Tk. 1.43 for July-December 2018. NOCFPS was Tk. 3.48 for July-December 2019 as against Tk. 3.49 for July-December 2018. NAV per share was Tk. 39.39 as on December 31, 2019 and Tk. 38.74 as on June 30, 2019. (cont.)

 

Trading Code: MHSML
News Title: MHSML: Q2 Financials
News: (Q2 Un-audited): EPS was Tk. (0.33) for October-December 2019 as against Tk. (0.15) for October-December 2018; EPS was Tk. (0.61) for July-December 2019 as against Tk. (0.27) for July-December 2018. NOCFPS was Tk. (1.32) for July-December 2019 as against Tk. 0.25 for July-December 2018. NAV per share was Tk. 14.69 as on December 31, 2019 and Tk. 15.61 as on June 30, 2019.

 

Trading Code: MARICO
News Title: MARICO: Q3 Financials
News: (Q3 Un-audited): EPS was Tk. 19.68 for October-December 2019 as against Tk. 16.47 for October-December 2018; EPS was Tk. 67.88 for April-December 2019 as against Tk. 49.39 for April-December 2018. NOCFPS was Tk. 85.42 for April-December 2019 as against Tk. 61.88 for April-December 2018. NAV per share was Tk. 58.36 as on December 31, 2019 and Tk. 40.49 as on March 31, 2019.

 

93 Comments

  3. nervecalm
    nervecalm on April 9, 2026 at 1:42 am

    NerveCalm is a high-quality nutritional supplement crafted to promote nerve wellness, ease chronic discomfort, and boost everyday vitality.

    Reply
  4. boostaro
    boostaro on April 9, 2026 at 1:42 am

    Boostaro is a modern mens wellness formula created to support daily vitality, stamina, and confidence through a practical, natural routine.

    Reply
  5. glpro
    glpro on April 9, 2026 at 1:42 am

    GL Pro is a natural dietary supplement formulated to help maintain steady, healthy blood sugar levels while easing persistent sugar cravings.

    Reply
  6. backbiome
    backbiome on April 9, 2026 at 1:42 am

    Backbiome is an advanced daily wellness supplement formulated to help support spinal comfort, reduce feelings of built-up tension, and promote freer, smoother movement throughout everyday life.

    Reply
  7. purdentix
    purdentix on April 9, 2026 at 1:42 am

    PurDentix is a revolutionary oral health supplement designed to support strong teeth and healthy gums. It tackles a wide range of dental concerns, including gum inflammation and tooth decay

    Reply
  8. aquasculpt
    aquasculpt on April 9, 2026 at 1:17 am

    AquaSculpt is a high-quality metabolic support supplement created to help the body utilize fat more efficiently while maintaining steady

    Reply
  9. webpage
    webpage on March 19, 2026 at 9:23 pm

    What’s up, every time i used to check web site posts here early in the dawn, because i like to learn more
    and more.

    Reply
  10. visium pro
    visium pro on March 19, 2026 at 2:10 pm

    Visium Pro is an advanced vision support formula created to help maintain eye health, sharpen visual performance, and provide daily support against modern challenges such as screen exposure and visual fatigue.

    Reply
  11. viriflow
    viriflow on March 19, 2026 at 2:10 pm

    ViriFlow is a dietary supplement formulated to help maintain prostate, bladder, and male reproductive health. Its blend of plant-based ingredients is designed to support urinary comfort and overall wellness as men age.

    Reply
  12. prostadine
    prostadine on March 19, 2026 at 11:28 am

    Prostadine concerns can disrupt everyday rhythm with steady discomfort, fueling frustration and a constant hunt for dependable relief.

    Reply
  13. prosta peak
    prosta peak on March 19, 2026 at 11:25 am

    Prosta Peak is a high-quality prostate wellness supplement formulated with a comprehensive blend of 20+ natural ingredients and essential nutrients to support prostate health

    Reply
  14. nitric boost
    nitric boost on March 19, 2026 at 11:07 am

    Nitric Boost Ultra is a daily wellness formula designed to enhance vitality and help support all-around performance.

    Reply
  15. prostafense
    prostafense on March 19, 2026 at 11:07 am

    ProstAfense is a premium, doctor-crafted supplement formulated to maintain optimal prostate function, enhance urinary performance, and support overall male wellness.

    Reply
  16. nervegenics
    nervegenics on March 19, 2026 at 11:04 am

    NerveGenics is a naturally formulated nerve-health supplement created to promote nerve comfort, cellular energy support, antioxidant defense

    Reply
  17. kerassentials
    kerassentials on March 19, 2026 at 11:02 am

    Kerassentials is an entirely natural blend crafted with 4 potent core oils and enriched by 9 complementary oils and vital minerals.

    Reply
  18. gluco6
    gluco6 on March 19, 2026 at 11:01 am

    Gluco6 is a natural, plant-based supplement designed to help maintain healthy blood sugar levels.

    Reply
  19. arialief
    arialief on March 19, 2026 at 11:00 am

    Arialief is a carefully developed dietary supplement designed to naturally support individuals dealing with sciatic nerve discomfort while promoting overall nerve wellness.

    Reply
  20. manergy
    manergy on March 19, 2026 at 11:00 am

    Manergy is an advanced male vitality supplement created to help support healthy testosterone levels

    Reply
  21. primebiome
    primebiome on March 19, 2026 at 10:53 am

    The bodys natural process of skin cell renewal is essential for preserving a smooth, healthy, and youthful-looking complexion.

    Reply
  22. prostavive
    prostavive on March 19, 2026 at 10:42 am

    Maintaining prostate health is crucial for men’s overall wellness, especially as they grow older. Conditions like reduced urine flow, interrupted sleep

    Reply
  23. insuleaf
    insuleaf on March 19, 2026 at 10:36 am

    InsuLeaf is a high-quality, naturally formulated supplement created to help maintain balanced blood glucose, support metabolic health, and boost overall vitality.

    Reply
  24. backbiome
    backbiome on March 19, 2026 at 10:23 am

    Backbiome is a naturally crafted, research-backed daily supplement formulated to gently relieve back tension and soothe sciatic discomfort.

    Reply
  25. aquasculpt
    aquasculpt on March 19, 2026 at 10:18 am

    AquaSculpt is a high-quality metabolic support supplement created to help the body utilize fat more efficiently while maintaining steady, reliable energy levels throughout the day.

    Reply
  26. purdentix
    purdentix on March 19, 2026 at 10:18 am

    PurDentix is a revolutionary oral health supplement designed to support strong teeth and healthy gums. It tackles a wide range of dental concerns

    Reply
  27. mitolyn
    mitolyn on March 19, 2026 at 10:06 am

    Mitolyn is a carefully developed, plant-based formula created to help support metabolic efficiency and encourage healthy, lasting weight management.

    Reply
  28. prodentim
    prodentim on March 19, 2026 at 10:02 am

    ProDentim is a distinctive oral-care formula that pairs targeted probiotics with plant-based ingredients to encourage strong teeth, comfortable gums, and reliably fresh breath.

    Reply
  29. back biome
    back biome on March 16, 2026 at 6:20 am

    **back biome**

    Backbiome is a naturally crafted, research-backed daily supplement formulated to gently relieve back tension and soothe sciatic discomfort.

    Reply
  30. backbiome
    backbiome on March 16, 2026 at 5:06 am

    **backbiome**

    Backbiome is a naturally crafted, research-backed daily supplement formulated to gently relieve back tension and soothe sciatic discomfort.

    Reply
  31. viagra sildenafil 50mg price
    viagra sildenafil 50mg price on February 20, 2026 at 10:38 pm

    You’ve made some good points there. I looked on the internet for additional information about the issue and found most individuals will go along with your views on this site.

    Reply
  32. cyclosporine eye drops
    cyclosporine eye drops on February 20, 2026 at 12:59 pm

    I am sure this piece of writing has touched all the internet users, its really really fastidious article on building up new webpage.

    Reply
  33. meloxicam medication
    meloxicam medication on February 17, 2026 at 1:48 am

    It’s very easy to find out any topic on web as compared to textbooks, as I found this post at this website.

    Reply
  35. nexium 40 mg capsules
    nexium 40 mg capsules on February 6, 2026 at 4:50 pm

    I am sure this piece of writing has touched all the internet viewers, its really really nice paragraph on building up new webpage.

    Reply
  36. mirtazapine medication
    mirtazapine medication on February 6, 2026 at 6:08 am

    Hurrah, that’s what I was searching for, what a stuff! existing here at this blog, thanks admin of this website.

    Reply
  38. ivermectin otc cream
    ivermectin otc cream on January 27, 2026 at 1:59 am

    Ahaa, its fastidious conversation concerning this paragraph here at this blog, I have read all that, so now me also commenting at this place.

    Reply
  39. rifaximin
    rifaximin on January 25, 2026 at 9:11 pm

    I will right away snatch your rss as I can’t to find your e-mail subscription link or e-newsletter service. Do you have any? Please allow me understand in order that I may just subscribe. Thanks.

    Reply
  41. atorvastatin have calcium
    atorvastatin have calcium on January 24, 2026 at 6:10 pm

    Wow, this article is good, my sister is analyzing these things, therefore I am going to inform her.

    Reply
  43. acyclovir dose in ckd
    acyclovir dose in ckd on January 18, 2026 at 3:49 am

    I will immediately take hold of your rss as I can not in finding your e-mail subscription link or e-newsletter service. Do you’ve any? Please allow me know in order that I could subscribe. Thanks.

    Reply
  45. order kamagra online
    order kamagra online on January 17, 2026 at 6:03 am

    I will immediately take hold of your rss feed as I can’t in finding your e-mail subscription link or e-newsletter service. Do you have any? Please allow me realize in order that I could subscribe. Thanks.

    Reply
  47. will furosemide lower sodium
    will furosemide lower sodium on January 9, 2026 at 8:49 pm

    I am sure this piece of writing has touched all the internet users, its really really good piece of writing on building up new web site.

    Reply
  48. fluconazole usp 150 mg
    fluconazole usp 150 mg on January 9, 2026 at 7:28 pm

    The slider has a bit of a spring action to it, meaning you only have to push it part of the way and the drive does the rest of the work for you.

    Reply
  49. is zithromax a penicillin
    is zithromax a penicillin on January 7, 2026 at 7:19 am

    There’s definately a great deal to know about this topic. I love all of the points you’ve made.

    Reply
  50. zithromax and heart problems
    zithromax and heart problems on January 7, 2026 at 3:31 am

    Heya i am for the first time here. I came across this board and I find It really useful & it helped me out much. I hope to give something back and help others like you helped me.

    Reply
  51. SarahK
    SarahK on November 11, 2025 at 5:52 am

    Helpful, much appreciated.

    Reply
  56. Prime Biome Reviews
    Prime Biome Reviews on April 4, 2025 at 5:03 am

    Your blog is a true hidden gem on the internet. Your thoughtful analysis and in-depth commentary set you apart from the crowd. Keep up the excellent work!

    Reply
  57. Hello
    Hello on March 14, 2025 at 5:39 pm

    EVDzuwk QTnWaRQ vfRqpaT kQDz jYZ gEn RviXaLYt

    Reply
  62. sed
    sed on February 21, 2025 at 11:48 pm

    yhbN3bXIzPC

    Reply
  64. wooned
    wooned on February 21, 2025 at 11:37 pm

    rlz3z04ETO7

    Reply
  69. culters
    culters on February 21, 2025 at 11:08 pm

    c3Ef9u2PUXA

    Reply
  70. magna
    magna on February 21, 2025 at 11:03 pm

    c9jYCO0XL8h

    Reply
  71. donec
    donec on February 21, 2025 at 10:57 pm

    pB6aQkyye3b

    Reply
  73. zits
    zits on February 21, 2025 at 10:46 pm

    ytzzAQ6njdr

    Reply
  75. calalu
    calalu on February 21, 2025 at 10:34 pm

    fXZzuNYjYTT

    Reply
  77. aenean
    aenean on February 21, 2025 at 10:23 pm

    G5efKK5EkVD

    Reply
  93. platea
    platea on February 21, 2025 at 2:37 pm

    QjWUsZiXOiv

    Reply

Trackbacks/Pingbacks

  1. kamagra recepty - kamagra online nákup jak získat předpis kamagra
  2. how to order xifaxan uk buy over counter - get xifaxan generic from canadian pharmacy get xifaxan buy online no prescription
  3. cheapest buy rifaximin purchase prescription - cheap rifaximin canadian pharmacy cheapest buy rifaximin cheap drugs
  4. canadian avodart no prescription - cheapest buy avodart generic low price ordering avodart generic when available
  5. buy cheap staxyn for sale usa - purchase staxyn purchase england buy cheap staxyn purchase from canada
  6. buy itraconazole cost australia - low testosterone and itraconazole buying itraconazole uk in store
  7. how to buy fildena generic canadian - buy cheap fildena purchase australia buy cheap fildena cheap canada pharmacy
  8. order gabapentin generic mastercard - gabapentin next day buy gabapentin buy adelaide
  9. online order dutasteride generic overnight delivery - dutasteride generic canada buy cheap dutasteride generic from india
  10. how to buy flexeril cyclobenzaprine cheap alternatives - flexeril cyclobenzaprine England over the counter ordering flexeril cyclobenzaprine buy safely online
  11. order androxal - purchase androxal usa suppliers order androxal medication interactions
  12. medicament kamagra sens ordonnance gratuit comprime - kamagra sans script générique kamagra pas cher au canada
  13. how to order enclomiphene cost new zealand - online order enclomiphene canadian discount pharmacy buy cheap enclomiphene australia no prescription

Leave a Reply to groundmass Cancel reply

Your email address will not be published. Required fields are marked *